EUVIMEDEUVIMED entdecken
Open Access

Generation of the RCPCMi014-A and RCPCMi014-B lines from T-lymphocytes of a healthy donor and verification of their monoclonal origin by TCR V(D)J rearrangement analysis

D K Sherman, M E Bogomiakova, E A Kastueva, I V Zvyagin, V K Ruppel, E V Barsova, A Y Gorbachev, N A Kulemin, A A Barinova, E A Zerkalenkova, A N Bogomazova, M A Lagarkova

Vavilov Journal of Genetics and Breeding · 26.05.2026 · 30 (3) · 362-371

DOI: 10.18699/vjgb-26-40 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vavilov Journal of Genetics and Breeding, online erschienen am 26.05.2026. Verfasst von D K Sherman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The generation of induced pluripotent stem cells (iPSCs) from peripheral blood T-lymphocytes offers a promising alternative to skin fibroblasts. This approach combines minimally invasive sample collection with rapid isolation of enriched target cell population and provides a lower baseline mutational burden, as T-lymphocytes are shielded from chronic ultraviolet radiation – a major driver of somatic mutations in skin fibroblasts. Objective verification of monoclonality of the resulting iPSC lines is possible due to V(D)J rearrangements in T-cell receptor (TCR) genes, which are formed as a result of somatic recombination in the thymus during the natural maturation of T-lymphocytes. These rearrangements remain unchanged during reprogramming and serve as a unique marker, allowing for reliable identification of monoclonal lines and exclusion of contaminated or polyclonal lines. Reliable verification of the clonal origin of iPSCs can be crucial in experiments that place high demands on genetic homogeneity. This work is dedicated to the generation and comprehensive characterization of monoclonal iPSC lines derived from CD3+ T-lymphocytes of a healthy donor using episomal reprogramming. The resulting lines, RCPCMi014-A (PBM022E5) and RCPCMi014-B (PBM022E7), meet the accepted quality criteria for iPSCs: they demonstrate expression of key pluripotency markers (OCT4, SOX2, SSEA-4, TRA-1-81), the ability to differentiate into derivatives of all three germ layers, and possess a normal karyotype. Both lines showed a high-efficiency capacity to differentiate into definitive endoderm, as assessed by CXCR4 expression, highlighting their potential for developing protocols to generate pancreatic β-cells. The obtained iPSC lines can be used for fundamental research into the mechanisms of pluripotency and differentiation, as well as for creating isogenic iPSC lines with introduced mutations for modeling rare hereditary diseases.

Schlagwörter

Stichwörter der Autor:innen

definitive endodermT-cell receptorT-lymphocytesV(D)J recombinationcell cloneinduced pluripotent stem cellsreprogramming

Autor:innen und Institutionen

  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Lopukhin Fed…
  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia LLC "MiLaboratori", Moscow, Russia.
  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia Pirogov Russian National Research Medical University, Moscow, Russia.

Zitieren

APA

Sherman, D. K., Bogomiakova, M. E., Kastueva, E. A., Zvyagin, I. V., Ruppel, V. K., Barsova, E. V., Gorbachev, A. Y., Kulemin, N. A., Barinova, A. A., Zerkalenkova, E. A., Bogomazova, A. N., & Lagarkova, M. A. (2026). Generation of the RCPCMi014-A and RCPCMi014-B lines from T-lymphocytes of a healthy donor and verification of their monoclonal origin by TCR V(D)J rearrangement analysis. Vavilov Journal of Genetics and Breeding, 30(3), 362-371. https://doi.org/10.18699/vjgb-26-40

Vancouver

Sherman DK, Bogomiakova ME, Kastueva EA, Zvyagin IV, Ruppel VK, Barsova EV, et al. Generation of the RCPCMi014-A and RCPCMi014-B lines from T-lymphocytes of a healthy donor and verification of their monoclonal origin by TCR V(D)J rearrangement analysis. Vavilov Journal of Genetics and Breeding. 2026;30(3):362-371. doi:10.18699/vjgb-26-40

BibTeX
@article{Sherman2026,
  author = {Sherman, D K and Bogomiakova, M E and Kastueva, E A and Zvyagin, I V and Ruppel, V K and Barsova, E V and Gorbachev, A Y and Kulemin, N A and Barinova, A A and Zerkalenkova, E A and Bogomazova, A N and Lagarkova, M A},
  title = {Generation of the RCPCMi014-A and RCPCMi014-B lines from T-lymphocytes of a healthy donor and verification of their monoclonal origin by TCR V(D)J rearrangement analysis},
  journal = {Vavilov Journal of Genetics and Breeding},
  year = {2026},
  volume = {30},
  number = {3},
  pages = {362--371},
  doi = {10.18699/vjgb-26-40}
}
Kostenlos starten →